- Home
- MIST vs NTRB Comparison
MIST vs NTRB Comparison
Compare MIST & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- NTRB
- Stock Information
- Founded
- MIST 2003
- NTRB 2016
- Country
- MIST Canada
- NTRB United States
- Employees
- MIST N/A
- NTRB N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- MIST Health Care
- NTRB Health Care
- Exchange
- MIST Nasdaq
- NTRB Nasdaq
- Market Cap
- MIST 89.8M
- NTRB 59.1M
- IPO Year
- MIST N/A
- NTRB N/A
- Fundamental
- Price
- MIST $1.60
- NTRB $8.00
- Analyst Decision
- MIST Strong Buy
- NTRB Buy
- Analyst Count
- MIST 2
- NTRB 1
- Target Price
- MIST $7.50
- NTRB $13.00
- AVG Volume (30 Days)
- MIST 1.8M
- NTRB 133.7K
- Earning Date
- MIST 08-07-2025
- NTRB 09-02-2025
- Dividend Yield
- MIST N/A
- NTRB N/A
- EPS Growth
- MIST N/A
- NTRB N/A
- EPS
- MIST N/A
- NTRB N/A
- Revenue
- MIST N/A
- NTRB $2,398,437.00
- Revenue This Year
- MIST N/A
- NTRB $560.75
- Revenue Next Year
- MIST N/A
- NTRB $588.39
- P/E Ratio
- MIST N/A
- NTRB N/A
- Revenue Growth
- MIST N/A
- NTRB 18.92
- 52 Week Low
- MIST $0.63
- NTRB $3.72
- 52 Week High
- MIST $2.75
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- MIST 83.15
- NTRB 51.71
- Support Level
- MIST $1.86
- NTRB $7.93
- Resistance Level
- MIST $1.97
- NTRB $11.68
- Average True Range (ATR)
- MIST 0.14
- NTRB 0.69
- MACD
- MIST 0.06
- NTRB -0.07
- Stochastic Oscillator
- MIST 100.00
- NTRB 20.96
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.